Common use of Preferred Shares Clause in Contracts

Preferred Shares. Immediately prior to the Closing, a total of 3,592,469 authorized series A-1 convertible preferred Shares with par value US$0.0001 per share of the Company (the “Series A-1 Preferred Shares”), a total of 11,920,990 authorized Series A-2 Preferred Shares with par value US$0.0001 per share of the Company (the “Series A-2 Preferred Shares” together with the Series A-1 Preferred Shares, the “Series A Preferred Shares”), a total of 10,579,436 authorized Series B-1 Preferred Shares with par value US$0.0001 per share of the Company (the “Series B-1 Preferred Shares”), a total of 1,389,064 authorized Series B-2 Preferred Shares with par value US$0.0001 per share of the Company (the “Series B-2 Preferred Shares”), a total of 7,298,927 authorized Series B-3 Preferred Shares with par value US$0.0001 per share of the Company (the “Series B-3 Preferred Shares”) and a total of 14,620,739 authorized Series B-4 Preferred Shares with par value US$0.0001 per share of the Company (the “Series B-4 Preferred Shares”, together with the Series B-1 Preferred Shares, the Series B-2 Preferred Shares, and the Series B-3 Preferred Shares, collectively the “Series B Preferred Shares”; the Series A Preferred Shares and the Series B Preferred Shares are collectively referred to as the “Preferred Shares”); the ordinary shares of the Company issuable upon conversion of the Series B-4 Preferred Shares will be collectively hereinafter referred to as the “Series B-4 Conversion Shares”, and the ordinary shares of the Company issuable upon conversion of the Preferred Shares will be collectively hereinafter referred to as the “Conversion Shares”), of which none was issued and outstanding.

Preferred Shares. Immediately prior to the Closing, a total of 3,592,469 2,075,502,060 Preferred Shares with par value US$0.000005 per share of the Company (the “Preferred Shares”), of which: (i) a total of 71,849,380 authorized series A-1 convertible preferred Shares with par value US$0.0001 0.000005 per share of the Company (the “Series A-1 Preferred Shares”), all of which are issued and outstanding; (ii) a total of 11,920,990 238,419,800 authorized Series series A-2 Preferred Shares with par value US$0.0001 0.000005 per share of the Company (the “Series A-2 Preferred Shares” and, together with the Series Series A-1 Preferred Shares, the “Series A Preferred Shares”), all of which are issued and outstanding; (iii) a total of 10,579,436 211,588,720 authorized Series series B-1 Preferred Shares with par value US$0.0001 0.000005 per share of the Company (the “Series B-1 Preferred Shares”), all of which are issued and outstanding; (iv) a total of 1,389,064 27,781,280 authorized Series series B-2 Preferred Shares with par value US$0.0001 0.000005 per share of the Company (the “Series B-2 Preferred Shares”), all of which are issued and outstanding; (v) a total of 7,298,927 145,978,540 authorized Series series B-3 Preferred Shares with par value US$0.0001 0.000005 per share of the Company (the “Series B-3 Preferred Shares”), all of which are issued and outstanding; and (vi) and a total of 14,620,739 292,414,780 authorized Series series B-4 Preferred Shares with par value US$0.0001 0.000005 per share of the Company (the “Series B-4 Preferred Shares”” and, together with the Series B-1 Preferred Shares, the Series B-2 Preferred Shares, and the Series B-3 Preferred Shares, collectively the “Series B Preferred Shares”; ), all of which are issued and outstanding; (vii) a total of 56,430,180 authorized Series C-1 Preferred Shares with par value US$0.000005 per share of the Company (the “Series C-1 Preferred Shares”), all of which are issued and outstanding; (viii) a total of 238,260,780 authorized Series C-2 Preferred Shares with par value US$0.000005 per share of the Company (the “Series C-2 Preferred Shares”), all of which are issued and outstanding; (ix) a total of 241,604,260 authorized Series C-3 Preferred Shares with par value US$0.000005 per share of the Company (the “Series C-3 Preferred Shares” and, together with the Series A C-1 Preferred Shares and the Series B C-2 Preferred Shares are collectively referred to as Shares, the “Series C Preferred Shares”); the ordinary shares of the Company issuable upon conversion of the Series B-4 Preferred Shares will be collectively hereinafter referred to as the “Series B-4 Conversion Shares”, and the ordinary shares of the Company issuable upon conversion of the Preferred Shares will be collectively hereinafter referred to as the “Conversion Shares”), all of which are issued or outstanding; and (x) a total of 551,174,340 authorized Series D Preferred Shares, none was of which is issued and or outstanding.

Preferred Shares. Immediately prior to the Closing, a A total of 3,592,469 290,368,628 authorized preferred shares, including (i) 78,824,567 series A-1 convertible E preferred Shares with shares of a par value of US$0.0001 per share of the Company each (the “Series A-1 Preferred E Shares”), all of which are issued and outstanding, (ii) 50,193,243 series D preferred shares of a total of 11,920,990 authorized Series A-2 Preferred Shares with par value of US$0.0001 per share of the Company each (the “Series A-2 Preferred D Shares” together with ”), all of which are issued and outstanding, (iii) 50,195,203 series C preferred shares of a par value of US$0.0001 each (the Series A-1 Preferred “Series C Shares”), all of which are issued and outstanding, (iv) 54,083,288 series B+ Shares of a par value of US$0.0001 each (the “Series B+ Shares”), all of which are issued and outstanding, (v) 34,815,112 series B preferred shares of a par value of US$0.0001 each (the “Series B Shares”), 34,544,762 of which are issued and outstanding, and (vi) 22,257,215 series A preferred shares of a par value of US$0.0001 each (the “Series A Preferred Shares”), a total of 10,579,436 authorized Series B-1 Preferred Shares with par value US$0.0001 per share of the Company (the “Series B-1 Preferred Shares”), a total of 1,389,064 authorized Series B-2 Preferred Shares with par value US$0.0001 per share of the Company (the “Series B-2 Preferred Shares”), a total of 7,298,927 authorized Series B-3 Preferred Shares with par value US$0.0001 per share of the Company (the “Series B-3 Preferred Shares”) and a total of 14,620,739 authorized Series B-4 Preferred Shares with par value US$0.0001 per share of the Company (the “Series B-4 Preferred Shares”, together with the Series B-1 Preferred E Shares, the Series B-2 Preferred D Shares, the Series C Shares, the Series B+ Shares and the Series B-3 Preferred B Shares, collectively the “Series B Existing Preferred Shares” and each, an “Existing Preferred Share”; ), 17,085,275 of which are issued and outstanding. The rights and preferences of each series of the Series A Preferred Shares and the Series B Existing Preferred Shares are collectively referred to as set forth in the “Preferred Shares”); the ordinary shares Fifth Amended and Restated Memorandum and Articles of Association of the Company issuable upon conversion which was adopted on January 12, 2018 (the “Existing Articles”). Each of the Series B-4 Existing Preferred Shares is convertible into Ordinary Shares on an initial ratio of 1:1, and no issuances have been made prior to the date hereof, or will be collectively hereinafter referred made prior to as the “Series B-4 Conversion Closing, which has had, should have had, or will have the effect of modifying the conversion ratio of any Existing Preferred Shares”, and the ordinary shares of the Company issuable upon conversion of the Preferred Shares will be collectively hereinafter referred to as the “Conversion Shares”), of which none was issued and outstanding.

Preferred Shares. Immediately prior to the ClosingClosing and after giving effect to the Restructuring, (i) a total of 3,592,469 6,427,914 authorized series A convertible preferred shares of the Company, par value of US$0.0001 per share (the “Series A Preferred Shares”), all of which shares are issued and outstanding; (ii) a total of 9,206,263 authorized series A-1 convertible preferred Shares with shares of the Company, par value of US$0.0001 per share of the Company (the “Series A-1 Preferred Shares”), all of which are issued and outstanding; (iii) a total of 11,920,990 2,138,438 authorized Series A-2 Preferred Shares with series B convertible preferred shares of the Company, par value of US$0.0001 per share of the Company (the “Series A-2 Preferred Shares” together with the Series A-1 Preferred Shares, the “Series A B Preferred Shares”), all of which shares are issued and outstanding; (iv) a total of 10,579,436 7,583,332 authorized Series B-1 Preferred Shares with convertible preferred shares of the Company, par value of US$0.0001 per 0.0001per share of the Company (the “Series B-1 Preferred Shares”), all of which shares are issued and outstanding; and (v) a total number of 1,389,064 13,787,829 authorized Series B-2 C Preferred Shares with Shares, par value of US$0.0001 per share share, none of which are issued and outstanding and all of which will be issued and outstanding upon Closing to the Company (the “Investors in such number as set forth opposite such Investors’ names on Schedule A attached hereto. Series B-2 A Preferred Shares”), a total of 7,298,927 authorized Series B-3 Preferred Shares with par value US$0.0001 per share of the Company (the “Series B-3 A-1 Preferred Shares”) and a total of 14,620,739 authorized , Series B-4 Preferred Shares with par value US$0.0001 per share of the Company (the “Series B-4 B Preferred Shares”, together with the Series B-1 Preferred Shares, the and Series B-2 Preferred Shares, and the Series B-3 Preferred Shares, collectively the “Series B Preferred Shares”; the Series A Preferred Shares and the Series B C Preferred Shares are collectively referred to collectively herein as the “Preferred Shares”); the ordinary shares of the Company issuable upon conversion of the Series B-4 Preferred Shares will be collectively hereinafter referred to as the “Series B-4 Conversion Shares”, and the ordinary shares of the Company issuable upon conversion of the Preferred Shares will be collectively hereinafter referred to as the “Conversion Shares”), of which none was issued and outstanding.